DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 31 · July 1998 DOI: 10.1055/s-002-6318

Original Papers

  • 117
    Sandmann, J.; Lörch, B.; Bandelow, B.; Härtter, S.; Winter, P.; Hiemke, C.; Benkert, O.:

    Fluvoxamine or Placebo in the Treatment of Panic Disorder and Relationship to Blood Concentrations of Fluvoxamine

  • 122
    Dose, M.; Hellweg, R.; Yassouridis, A.; Theison, M.; Emrich, H. M.:

    Combined Treatment of Schizophrenic Psychoses with Haloperidol and Valproate

  • 126
    Hatta, K.; Takahashi, T.; Nakamura, H.; Yamashiro, H.; Endo, H.; Kito, K.; Saeki, T.; Masui, K.; Yonezawa, Y.:

    A Risk for Obstruction of the Airways in the Parenteral Use of Levomepromazine with Benzodiazepine

  • 131
    Santagostino, G.; Cucchi, Maria Laura; Frattini, P.; Zerbi, F.; Di Paolo, E.; Preda, Stefania; Corona, G. L.:

    The Influence of Alprazolam on the Monoaminergic Neurotransmitter Systems in Dysthymic Patients. Relationship to Clinical Response

  • 137
  • Case Reports

  • 143
    Bonnet, U.; Banger, M.; Wolstein, J.; Gastpar, M.:

    Choreoathetoid Movements Associated with Rapid Adjustment to Methadone

  • 146
    Jauss, M.; Schröder, J.; Pantel, J.; Bachmann, S.; Gerdsen, I.; Mundt, Ch.:

    Severe Akathisia during Olanzapine Treatment of Acute Schizophrenia

  • 149
  • 152
    Braun, J. S.; Geiger, R.; Wehner, H.; Schäffer, S.; Berger, M.:

    Hepatitis Caused by Antidepressive Therapy with Maprotiline and Opipramol

  • 156